文献速递衰弱、肌少症与跌倒老年综合评估

社区老年人肌少症风险预测列线图的开发与验证

Development and Validation of a Nomogram for Predicting Sarcopenia in Community-Dwelling Older Adults.
PubMed 文献 · J Am Med Dir Assoc · 2021-12-20

该回顾性研究基于中国湖南1050名社区老年人(≥60岁)调查数据,按2019年亚洲肌少症工作组标准诊断肌少症,发现患病率为25.0%。

要点

  • 社区老年人肌少症患病率为25.0%,年龄、BMI、婚姻状况、规律运动、久坐时间和膳食多样性是独立危险因素。
  • 列线图预测肌少症风险开发集AUC为0.827(95%CI 0.792-0.860),验证集AUC为0.755(95%CI 0.680-0.837),校准良好。
  • 风险分层为低危(<11%)、中危(11%-70%)和高危(>70%),可用于早期干预和分级管理。

核心结论

  • 该研究开发并验证了社区老年人肌少症风险预测列线图,具有较好的判别能力和校准度,可为医护人员、照护者和老年人提供预测、早期干预和分级管理的可视化工具。

研究设计与样本

  • 回顾性研究,纳入2019年6月至9月中国湖南社区老年人(≥60岁)共1050名,随机分为开发集和验证集,采用多因素logistic回归筛选独立危险因素并构建列线图。

主要发现

  • 263名(25.0%)参与者被诊断为肌少症。
  • 年龄、体质指数、婚姻状况、规律体育活动习惯、不间断久坐时间和膳食多样性评分是肌少症的显著贡献因素。
  • 开发集AUC为0.827(95%CI 0.792-0.860),验证集AUC为0.755(95%CI 0.680-0.837)。
  • 决策曲线分析显示两个集均有较高净获益。

关键数值与推荐

  • 肌少症诊断依据2019年亚洲肌少症工作组(AWGS)标准。
  • 列线图风险分层:低危(<11%)、中危(11%-70%)、高危(>70%)。

临床怎么用

  • 在社区老年健康管理中,可依据列线图评估肌少症风险,对中高危个体尽早启动营养、运动等干预,并实施分级管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To establish and validate a nomogram that predicts the risk of sarcopenia for community-dwelling older residents. DESIGN: Retrospective study. SETTING AND PARTICIPANTS: A total of 1050 community-dwelling older adults. METHODS: Data from a survey of community-dwelling older residents (≥60 years old) in Hunan, China, from June to September 2019 were retrospectively analyzed. The survey included general demographic information, diet, and exercise habits. Sarcopenia diagnosis was according to 2019 Asian Working Group for Sarcopenia criteria. Participants were randomly divided into the development group and validation groups. Independent risk factors were screened by multivariate logistic regression analysis. Based on the independent risk factors, a nomogram model was developed to predict the risk of sarcopenia for community-dwelling older adults. Both in the development and validation sets, the discrimination, calibration, and clinical practicability of the nomogram were verified using receiver operating characteristic curve analysis, Hosmer-Lemeshow test, and decision curve analysis, respectively. RESULTS: Sarcopenia was identified in 263 (25.0%) participants. Age, body mass index, marital status, regular physical activity habit, uninterrupted sedentary time, and dietary diversity score were significant contributors to sarcopenia risk. A nomogram for predicting sarcopenia in community-dwelling older adults was developed using these factors. Receiver operating characteristic curve analysis showed that the area under the curve was 0.827 (95% CI 0.792-0.860) and 0.755 (95% CI 0.680-0.837) in the development and validation sets, respectively. The Hosmer-Lemeshow test yielded P values of .609 and .565, respectively, for the 2 sets. The nomogram demonstrated a high net benefit in the clinical decision curve in both sets. CONCLUSIONS AND IMPLICATIONS: This study developed and validated a risk prediction nomogram for sarcopenia among community-dwelling older adults. Sarcopenia risk was classified as low (<11%), moderate (11%-70%), and high (>70%). This nomogram provides an accurate visual tool to medical staff, caregivers, and older adults for prediction, early intervention, and graded management of sarcopenia.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Mo YH, Su YD, Dong X, et al. Development and Validation of a Nomogram for Predicting Sarcopenia in Community-Dwelling Older Adults. J Am Med Dir Assoc. 2021. PMID: 34932988. doi:10.1016/j.jamda.2021.11.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。